RESIDUAL INFLAMMATORY RISK

Clinical trials for RESIDUAL INFLAMMATORY RISK explained in plain language.

Never miss a new study

Get alerted when new RESIDUAL INFLAMMATORY RISK trials appear

Sign up with your email to follow new studies for RESIDUAL INFLAMMATORY RISK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Scientists hunt for hidden clues in heart Patients' blood

Knowledge-focused Not yet recruiting

This study aims to understand how a low-dose anti-inflammatory drug (colchicine) changes the mix of proteins in the blood of people with coronary heart disease who still have inflammation. Researchers will compare blood samples from 176 patients, half taking the drug and half not…

Matched conditions: RESIDUAL INFLAMMATORY RISK

Phase: PHASE4 • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Knowledge-focused

Last updated Mar 23, 2026 15:16 UTC

RESIDUAL INFLAMMATORY RISK

Get alerted when new RESIDUAL INFLAMMATORY RISK trials appear

Scientists hunt for hidden clues in heart Patients' blood